The findings and conclusions in these presentations have not been formally disseminated by the Centers for Disease Control and Prevention and should not be construed to represent any agency determination or policy.

Tuesday, May 9, 2006 - 11:00 AM
42

Cost effectiveness models of HPV vaccines

Harrell W. Chesson, Division of STD Prevention, CDC, Atlanta, GA, USA

Text Not Available.

See more of HPV vaccine - Information for development of recommendations and vaccine implementation
See more of Symposium

See more of The 2006 National STD Prevention Conference